366 related articles for article (PubMed ID: 36568259)
1. Modulatory role of miRNAs in thyroid and breast cancer progression and insights into their therapeutic manipulation.
Ahmed R; Samanta S; Banerjee J; Kar SS; Dash SK
Curr Res Pharmacol Drug Discov; 2022; 3():100131. PubMed ID: 36568259
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
3. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
4. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
[TBL] [Abstract][Full Text] [Related]
8. Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention.
Sengupta D; Deb M; Kar S; Pradhan N; Parbin S; Kirtana R; Singh SP; Suma SG; Niharika ; Roy A; Manna S; Saha P; Chakraborty P; Dash S; Kausar C; Patra SK
Semin Cancer Biol; 2021 Jul; 72():46-64. PubMed ID: 32497683
[TBL] [Abstract][Full Text] [Related]
9. miRNA-Directed Regulation of the Main Signaling Pathways in Thyroid Cancer.
Ramírez-Moya J; Santisteban P
Front Endocrinol (Lausanne); 2019; 10():430. PubMed ID: 31312183
[TBL] [Abstract][Full Text] [Related]
10. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
12. Increased microRNA activity in human cancers.
Israel A; Sharan R; Ruppin E; Galun E
PLoS One; 2009 Jun; 4(6):e6045. PubMed ID: 19557174
[TBL] [Abstract][Full Text] [Related]
13. High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Leivonen SK; Sahlberg KK; Mäkelä R; Due EU; Kallioniemi O; Børresen-Dale AL; Perälä M
Mol Oncol; 2014 Feb; 8(1):93-104. PubMed ID: 24148764
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
15. microRNAs as oncogenes and tumor suppressors.
Zhang B; Pan X; Cobb GP; Anderson TA
Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
[TBL] [Abstract][Full Text] [Related]
16. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
[TBL] [Abstract][Full Text] [Related]
17. Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells.
Banerjee S; Mandal AKA
Front Genet; 2022; 13():995046. PubMed ID: 36276982
[TBL] [Abstract][Full Text] [Related]
18. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA in forming breast carcinoma.
Saikia M; Paul S; Chakraborty S
Life Sci; 2020 Oct; 259():118256. PubMed ID: 32822719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
